localizes O
yellow O
four O
aggression O
SPK I-GENE
Western O
SPB O
Galpha I-GENE
hormone I-GENE
SP1 I-GENE
regional O
experimentally O
polyacrylamide O
elevations O
differentiated O
+/- O
JNK I-GENE
chloroplast I-GENE
cytomegalovirus I-GENE
pulse O
270 O
consists O
272 O
elegans I-GENE
NO2 O
contributed O
fingers O
postoperative O
localized O
heterotrimeric I-GENE
increasing O
H19 I-GENE
reporter I-GENE
here O
herd O
reported O
GRE I-GENE
pancreas O
catalyzes O
coexpressed O
etiology O
Alternative O
catalyzed O
HLA I-GENE
interferon I-GENE
classification O
explained O
Three O
replace O
psychological O
p44 I-GENE
unit I-GENE
p40 I-GENE
derivatives O
METHODS O
mAb I-GENE
therefore O
until O
Recent O
females O
standardized O
populations O
successful O
43 I-GENE
99 O
glass O
export O
reversible O
91 O
90 O
93 O
92 O
95 O
94 O
97 O
96 O
intake O
LMP I-GENE
Lung O
temperatures O
cytochrome I-GENE
example O
La I-GENE
organized O
Li O
absolute O
GnRH I-GENE
LA O
damage O
LH I-GENE
machine O
how O
hot O
significance O
Sequencing O
agglutination I-GENE
translocation O
A I-GENE
saline O
PEPCK I-GENE
modulation O
L2 O
L1 I-GENE
types O
calves O
effective O
recombination O
orally O
Another O
restriction I-GENE
AP2 I-GENE
antisense I-GENE
vary O
fidelity I-GENE
activating I-GENE
shorter O
His O
ligand O
fit O
auditory O
folate I-GENE
Overexpression O
MRP I-GENE
MRS O
hypoxic O
hypoxia O
MRI O
silver O
structural O
represents O
(+/- O
Functional O
coronavirus O
APC I-GENE
interfering O
integrase I-GENE
series O
platelets O
displacement I-GENE
neuroleptic O
substantially O
laboratory O
rs O
thrombin I-GENE
re O
unrelated O
University O
given O
sensory O
estimate O
silent I-GENE
chemotactic O
diabetic O
Human I-GENE
steroids O
vitro O
channels I-GENE
oncogenic I-GENE
force O
175 O
170 I-GENE
seizures O
similarly O
Effect O
codons O
needed O
glucocorticoid I-GENE
ranging O
Trypanosoma O
positively O
feasibility O
showed O
Data O
second O
mitogen I-GENE
regulator I-GENE
pneumonia O
pseudorabies O
acquisition O
myositis O
spectrum O
antagonistic O
PGF2 O
Asp I-GENE
responsible O
recommended O
Inhibition O
absorbed O
They O
Asn O
mouth O
vaccinia I-GENE
breakpoint I-GENE
initiator O
introns O
immunoreactivity O
hypotensive O
mating I-GENE
incomplete O
soluble I-GENE
ulcer O
participate O
lethal O
kinase I-GENE
exonuclease I-GENE
maturation O
rich O
rice I-GENE
plate I-GENE
Nevertheless O
psychiatric O
pocket O
reversal O
X I-GENE
IgM I-GENE
superfamily I-GENE
sporulation I-GENE
rectal O
patch O
flanked O
release O
Purified I-GENE
respond O
sensitivity O
UAS1 O
transferred O
result O
fail O
best O
oncogene I-GENE
Risk O
Caenorhabditis I-GENE
pressures O
score O
never O
extend O
nature O
eukaryotic I-GENE
extent O
carbon O
topology O
PSI I-GENE
triggers O
adapter I-GENE
PSA I-GENE
deposition O
GABP I-GENE
iron O
genus O
adapted O
GABA I-GENE
BCL I-GENE
and O
alternate O
HNF I-GENE
BCG O
258 O
pregnancy O
250 O
256 O
BCR I-GENE
. O
extraction O
much O
beta2 I-GENE
Wnt I-GENE
progenitor I-GENE
contraction O
ABSTRACT O
Acute O
life O
SRF I-GENE
SRE O
hospitalized O
relevance O
fibroblast I-GENE
child O
spin O
NMR O
calcium O
p62 I-GENE
p65 I-GENE
played O
polyadenylation O
conditioned O
U937 O
characterize O
elicit O
reports O
Assessment O
damaged O
severity O
cumulative O
babies O
templates O
myocardial O
subgroups O
ventricles O
EBV I-GENE
EBP I-GENE
contractility O
simulated O
quantitative O
plaque O
decreasing O
DRE I-GENE
previous O
atrial I-GENE
inotropic O
irradiated O
had O
has O
elevation O
survival O
possible O
possibly O
indicative O
birth O
clustered O
unique O
occurring O
DR1 I-GENE
%; O
steps O
proliferator I-GENE
Further O
beneficial O
right O
old O
truncated I-GENE
insertional I-GENE
fibroblasts O
cocaine O
for O
fos I-GENE
repression O
nitrate I-GENE
diltiazem O
dental O
substituted O
diploid O
3T3 O
First O
disorder O
adipose I-GENE
o I-GENE
lacked O
slightly O
Use O
reducing O
novo I-GENE
altitude O
resulted O
myocyte I-GENE
offer O
forming O
hemisphere O
incorporation O
Interferon I-GENE
endocytic O
arrays O
readthrough O
immunologic O
complications O
151 O
150 O
juvenile O
proved O
154 O
156 I-GENE
steady O
Six O
BamHI I-GENE
proven O
exist O
'. O
'- O
', O
') I-GENE
melanoma O
floor I-GENE
role O
conferring O
trafficking O
E I-GENE
2721 O
models O
cleaved O
birds O
variable O
transporter I-GENE
noradrenergic O
98 O
aerobic O
time O
conferred O
urinary O
irrigation O
polypeptides I-GENE
chain I-GENE
activated I-GENE
aspartate I-GENE
asymptomatic O
:: O
activates O
amplification O
recurrence O
choice O
minute O
Tat I-GENE
discovered O
tear I-GENE
Tax I-GENE
prevent O
occurrence O
findings O
prediction O
sign O
imprinting O
M1 I-GENE
agonists O
current O
hsp70 I-GENE
overexpressed O
Mg I-GENE
Mb O
understanding O
shortened O
splice O
address O
alone O
ratio O
along O
MA I-GENE
MC O
MB I-GENE
studied O
MI O
commonly O
MP I-GENE
MS O
MR O
studies O
tasks O
kilobases O
myoglobin I-GENE
undergone O
August O
working O
positive O
predictions O
tightly O
anatomical O
opposed O
films O
enriched O
resuscitation O
heterodimers I-GENE
Isolation O
apparent O
validity O
Streptococcus I-GENE
visual O
polypeptide I-GENE
facilitating O
abortion O
cutaneous O
values O
following O
Our O
zippers I-GENE
endonuclease I-GENE
239 O
allowed O
BAL I-GENE
231 O
233 I-GENE
monitoring O
divided O
immune I-GENE
Significant O
optimal O
parameter O
transactivating O
STK I-GENE
applications O
explored O
cardiac O
such O
revealed O
stress O
natural O
correlate O
conscious O
NCR O
sp O
sclerosis O
so O
sc O
hematopoietic I-GENE
LIM I-GENE
epilepsy O
p85 I-GENE
years O
course O
episodes O
experiments O
terminase I-GENE
tendency O
LV O
decreases O
constitutes O
torr O
decreased O
chromatin O
thereby O
matches O
regarding O
records O
exon O
maintaining O
matched O
ranitidine O
prophylaxis O
coagulation I-GENE
square O
Transcription O
revised O
bovine I-GENE
methotrexate O
Ischemic O
Cdc2 I-GENE
contained O
investigation O
trauma O
suggesting O
formula O
million O
inhaled O
possibility O
quite O
recordings O
complicated O
mitogenic O
training O
interacted O
PEA3 I-GENE
initiate O
routes O
plasminogen I-GENE
ATF I-GENE
ATG O
distal O
one O
specifically O
ATP I-GENE
open O
structured O
fms I-GENE
indicate O
2 I-GENE
constants O
structures O
apoptotic O
meiotic I-GENE
representing O
hyperplasia O
depressed O
future O
diastolic O
illness O
turned O
locations O
bacilli O
inhibiting O
NANB O
neutropenia O
transcribed O
take O
VDRE I-GENE
altered O
opposite O
molecule I-GENE
EDTA O
inserted O
average O
infections O
drive O
Chem O
salt O
oncogenes I-GENE
definite O
proteoglycan I-GENE
fecal O
surgically O
aggressive O
Cys I-GENE
fibre O
slow O
conduction O
phospholipids O
actin I-GENE
virion O
excision O
AP1 I-GENE
morphological O
recombinant I-GENE
resource O
esophageal O
where O
vision O
attenuated O
Specifically O
attenuates O
DESIGN O
us O
heifers O
surgery O
cortisol O
compounds O
sites I-GENE
vaccines O
affecting O
mature O
vertical O
tandemly O
screen O
suppresses O
steroid I-GENE
suppressed O
Hodgkin O
many O
s O
expression O
uORF I-GENE
FSH I-GENE
anti I-GENE
dislocation O
stretch O
locally O
incubation O
combined O
prototype O
reflex O
formed O
photon O
observe O
former O
resides O
hypertrophy O
mono O
prevalence O
C18 O
proteolytic O
technology O
inoculated O
Blood O
subdomain I-GENE
PCNA I-GENE
I I-GENE
IRS I-GENE
structurally O
UTR I-GENE
hydroxylase I-GENE
IRF I-GENE
pacing O
xylene O
costs O
HDL2 I-GENE
effects O
summer O
215 O
NAD I-GENE
being O
rest O
HBV O
weekly O
Streptomyces I-GENE
interstitial O
occluded O
instrument O
hybrids O
HBs I-GENE
aspects O
around O
(< O
dark O
(+ O
preference O
(- O
(" O
world O
thyroiditis O
malignancy O
pol I-GENE
63 O
colon O
Myc I-GENE
Myb I-GENE
stationary O
intestinal O
satisfactory O
conditional O
FLI I-GENE
PDGF I-GENE
complementarity I-GENE
interleukin I-GENE
dimensions O
cavity O
tube O
pathogenesis O
power O
uterine O
retains O
retinoic I-GENE
retinoid I-GENE
ratios O
mmol O
Restriction O
stone O
origins O
mediate O
side O
tumor I-GENE
KCS I-GENE
act O
mean O
lytic O
No O
Na I-GENE
image O
accumulates O
pyrimidine O
accumulated O
Increasing O
NK I-GENE
her I-GENE
NO O
NA O
NE O
NF I-GENE
secretion O
NP I-GENE
NS I-GENE
rCBF O
ICP4 I-GENE
complete O
octamer O
secreted O
mammals O
cloned O
follicular O
clones O
N1 O
mice O
parasites O
with O
regimen O
aa O
deferens O
certain O
histocompatibility I-GENE
al O
an O
as O
hypertension O
at O
formulation O
Hox I-GENE
cream O
aromatic O
spatial O
Cyclin I-GENE
gyrus O
spermatozoa O
catalytically O
gastric O
acids O
Direct I-GENE
gastrin I-GENE
mimic O
mast I-GENE
mass O
behavioral O
original O
splicing O
influenza I-GENE
consider O
caused O
code O
causes O
HML I-GENE
ts I-GENE
to O
tail O
tk I-GENE
centromere O
endogenous I-GENE
degeneration O
returned O
subunits I-GENE
blockade O
strand O
potentiation O
accompanying O
phosphorylation O
t1 O
large O
small I-GENE
antibiotic O
198 O
190 O
193 O
192 I-GENE
past O
fractionation O
displays O
lipids O
hormonal O
section O
transactivator I-GENE
nurse O
method O
contrast O
dimerization O
full I-GENE
hours O
transformation O
allergens O
striatum I-GENE
thymidine I-GENE
compliance O
experience O
prior O
periodic I-GENE
hamster I-GENE
social O
cessation O
via O
followed O
regimens O
select O
alcoholic O
integrin I-GENE
magnification O
6 I-GENE
Nucleotide O
more O
proliferative O
testes O
substances O
corrected O
emission O
tested O
haemodialysis O
evolved O
male O
Rhizobium I-GENE
antagonists O
myristate O
scan O
states O
sense O
axis O
information O
respective O
plant O
variant I-GENE
treatments O
phenotypes O
cotransfected O
waves O
organization O
E2F1 I-GENE
Tissue I-GENE
thaliana O
saccharin O
paper O
signs O
its O
roots O
scintigraphy O
rapidly O
termed O
polymerases I-GENE
conjugation O
symptoms O
bypass O
tentatively O
hysterectomy O
entire O
propose O
_RARE_ I-GENE
C3H O
always O
Resistance O
labeling O
courses O
found O
status O
IX I-GENE
contiguous O
reduce O
fewer O
doses O
operation O
HDL I-GENE
penicillin I-GENE
repressive O
SH2 I-GENE
SH3 I-GENE
BMD O
BMI O
research O
BMP I-GENE
occurs O
SHP I-GENE
localization O
antisera O
imaging O
airway O
II I-GENE
pairs O
retained O
carboxy I-GENE
TBP I-GENE
positioning O
w O
exhibited O
major I-GENE
thereafter O
number O
preservation O
IA O
differ O
introduction O
moderately O
checkpoint I-GENE
adenovirus I-GENE
molecular O
PPARalpha I-GENE
relationship O
immediate I-GENE
focusing O
modes O
diffusion O
Cancer O
tooth O
determined O
PD98059 O
oestradiol O
defect O
micrograms O
adding O
precipitating O
self O
also O
internal O
generalized O
play O
lesioned O
nasal O
phosphoprotein I-GENE
virus I-GENE
cause O
Ig I-GENE
session O
degraded O
impact O
indicator O
failed O
enzyme I-GENE
cassette I-GENE
YAC O
factor I-GENE
cholinesterase I-GENE
BRCA1 I-GENE
dependent I-GENE
SETTING O
allergen I-GENE
untreated O
inducible I-GENE
progressive O
tumors O
set O
For O
Fos I-GENE
potent O
sex I-GENE
sec O
migration O
sea O
analog O
Tyrosine I-GENE
guinea O
eIF3 I-GENE
fission I-GENE
acidic O
EMSA O
available O
kilobase O
targeted O
selectively O
interface O
vesicles O
last O
PURPOSE O
retarded O
whole O
homologue I-GENE
purified O
): O
YY1 I-GENE
corresponds O
community O
)) O
)( I-GENE
)+ O
)- I-GENE
adaptation O
)/ O
). O
monthly O
initiation I-GENE
capsid I-GENE
multisubunit I-GENE
silencer I-GENE
representative O
systematic O
ligands O
formate O
)] O
reliable O
Marked O
evaluating O
error O
nucleotides O
von I-GENE
binding I-GENE
triple O
mediating O
fibers O
elevated O
prothrombin I-GENE
cholinergic O
virtually O
survey O
levels O
NIH3T3 O
focal I-GENE
recent O
serologic O
Rats I-GENE
infertility O
Sos I-GENE
regulating O
normals O
clearance O
comprise O
construct I-GENE
FR I-GENE
O2 O
globin I-GENE
dissociation O
conclusions O
admission O
hsp90 I-GENE
reactivity O
signals O
RACE O
parents O
location O
disulfide O
input O
On O
victims O
Of O
suffering O
clindamycin O
sorting I-GENE
d O
OH O
spine O
OC I-GENE
retrovirus O
consensus I-GENE
individuals O
yields O
erythematosus O
OR O
COUP I-GENE
methods O
DER I-GENE
measurements O
derepression O
Vmax O
inserting O
be O
phosphopeptides O
agreement O
bp O
tidal O
by O
differentially O
secretory I-GENE
cotransfection O
anterior O
repair I-GENE
ACA I-GENE
cycloheximide I-GENE
ACE I-GENE
into O
helical O
integral I-GENE
locus I-GENE
appropriate O
mitochondrial I-GENE
primarily O
RING I-GENE
methylene O
span O
gases O
adenocarcinoma O
cDNAs I-GENE
lipopolysaccharide O
considerably O
ligation O
retina O
link I-GENE
ATPase I-GENE
protooncogene I-GENE
line O
considerable O
GDP I-GENE
MEF I-GENE
noradrenaline O
up O
MEK I-GENE
cis O
paired I-GENE
spectroscopy O
pineal O
continuously O
transcriptional O
defined O
influence O
diverse O
International O
questionnaire O
defines O
codes O
preventing O
adjuvant O
coded O
elements O
developmental O
LEU2 I-GENE
suppression O
sides O
algorithm O
age O
kinetics O
enrolled O
retardation O
fresh O
having O
CPK I-GENE
partial O
CPB O
results O
existing O
CPT I-GENE
centers O
young O
Candida I-GENE
monoamine I-GENE
indicating O
>/= O
F2 O
developmentally O
urease I-GENE
continued O
categories O
trk I-GENE
harbor O
catabolite I-GENE
obesity O
Primer O
Sodium O
recruitment O
imply O
wheat I-GENE
dynamics O
index O
angiographic O
apparatus O
expressed O
hereditary I-GENE
consistently O
Escherichia I-GENE
proliferation O
led O
fertilization O
respectively O
dentin O
physiology O
deduced O
great O
receive O
involved O
acetyltransferase I-GENE
resulting O
insulin I-GENE
makes O
involves O
serotype I-GENE
outcomes O
oligomerization O
tools O
confidence O
perfusion O
Myocardial O
dismutase I-GENE
next O
chloride O
comparison O
occurred O
carrying O
labelled O
sharply O
isoflurane O
resection O
animals O
this O
challenge O
erythroid I-GENE
hydrolysis O
thin O
radiographs O
PAGE O
process O
loci I-GENE
high O
coenzyme I-GENE
HSP70 I-GENE
Several O
hydrophilic O
delay O
animal O
hormones O
venous O
establishment O
blocks O
Q I-GENE
pigs O
meiosis O
marrow O
efficiently O
tomato I-GENE
microbial I-GENE
One O
allow O
lactate I-GENE
volunteers O
evolutionary O
produces O
insight O
transcriptionally O
produced O
directs O
gonadotropin I-GENE
operative O
perfect O
decay O
chosen O
microglobulin I-GENE
mellitus O
degrees O
derivative O
suppressor I-GENE
physicians O
disrupted O
Jurkat O
afferents O
VII I-GENE
PATIENTS O
electrically O
accompanied O
tracer O
subset O
STAT I-GENE
deficiency O
fibronectin I-GENE
frequency O
activin I-GENE
mediates O
matrix I-GENE
' O
valve O
mediated O
motifs O
adaptive O
interactions O
regulators O
regulatory I-GENE
could O
length I-GENE
removing O
repeats I-GENE
stimulate O
demonstrating O
450 I-GENE
collagen I-GENE
bacterially O
Basal O
system O
mumol O
Adult O
peripheral O
stomach O
adaptor I-GENE
UNC I-GENE
PC12 O
Cdc28 I-GENE
reacted O
negatively O
pertussis I-GENE
cloning O
false O
Results O
AAV I-GENE
affinities O
element I-GENE
clearly O
overexpressing O
ERKs I-GENE
bacterium O
studying O
mechanism O
septal O
peroxidase I-GENE
accuracy O
device O
SLE O
segment O
ERK1 I-GENE
ERK2 I-GENE
placement O
GFR O
stronger O
face O
epithelium O
mechanical O
fact O
HSF1 I-GENE
terminate O
artificial O
Under O
cyclase I-GENE
principal O
bZIP I-GENE
spliceosome O
jaw O
technetium O
should O
terminal I-GENE
molecules I-GENE
biogenesis O
capsules O
bonds O
pathophysiology O
familial O
sinus O
antagonist O
Once O
Because O
metabolite O
circulation O
h O
intervening O
CRS I-GENE
CRP I-GENE
Px I-GENE
correlations O
Gbetagamma I-GENE
CRF I-GENE
multicopy O
CRE O
prostaglandins O
electrode O
Intravenous O
PR I-GENE
PS I-GENE
PP I-GENE
interacting I-GENE
PT O
PU I-GENE
nuclear I-GENE
albumin I-GENE
carcinomas O
PC I-GENE
PA I-GENE
methionine O
PD I-GENE
PE I-GENE
PK I-GENE
PH I-GENE
PI I-GENE
PL I-GENE
P2 I-GENE
P3 I-GENE
ends O
P1 I-GENE
P7 I-GENE
P4 I-GENE
notion O
configuration O
ets I-GENE
deficits O
drug O
etc O
adjusted O
co O
cm O
conclude O
allocated O
cv O
ultrasonography O
naltrexone O
hepatoma O
genetic O
utilizing O
> O
meningitis O
lymphoid I-GENE
laser O
middle I-GENE
pharmacokinetic O
helicase I-GENE
PTCA O
site I-GENE
vs O
35S I-GENE
branchpoint O
situ O
cohort O
infarction O
outbreak O
EBNA I-GENE
cGMP I-GENE
phi I-GENE
complemented O
upon O
obese O
dust O
mosaic O
diabetes O
lupus O
off O
colour I-GENE
chemokine I-GENE
patterns O
administered O
subgroup O
less O
predicts O
luciferase I-GENE
transactivates O
arrest O
increased O
ferritin I-GENE
increases O
five O
atrophy O
cerevisiae I-GENE
membrane I-GENE
heterodimeric I-GENE
placenta O
thrombosis O
resin O
parasite O
become O
neutrophils O
therapeutic O
opioid I-GENE
CNV O
Addition O
underwent O
phenylalanine I-GENE
VO2 O
Histological O
recognition I-GENE
avoid O
does O
schedule O
selenocysteine I-GENE
hemodialysis O
lethality O
pressure O
abdominal O
stage O
insufficient O
swimming O
C2C12 O
contractions O
assess O
lung O
larvae O
larval I-GENE
spots O
specimens O
naturally O
function O
beta1 I-GENE
Interestingly O
overlapping O
delivery O
lowered O
ethylene O
count O
evident O
smooth I-GENE
allelic O
catecholamines O
placed O
problem O
odds O
CIC I-GENE
bearing O
phenytoin O
int I-GENE
recognize O
contribute O
Clinical O
epithelial O
anesthesia O
nuclease I-GENE
compared O
efficacy O
variety O
tubular O
predominant O
Structure O
repeat I-GENE
neuroblastoma O
U O
idiopathic O
vein O
exposure O
SRP I-GENE
compete O
ischaemic O
ischaemia O
alleles I-GENE
magnetic O
Rous I-GENE
dysplasia O
CR I-GENE
helices O
integrity O
relationships O
oocyte O
physiological O
ventral O
cm3 O
cm2 O
replication O
peroxidation O
MAP I-GENE
progression O
disc O
indices O
293 O
MAO I-GENE
Klebsiella I-GENE
resorption O
spontaneously O
intravenously O
established O
filtration O
+ I-GENE
bipolar O
intrahepatic O
phosphotyrosine I-GENE
above O
consisting O
polarity O
simultaneously O
residual O
endothelium O
protection O
stresses O
balance O
daughter O
study O
SECIS O
neurones O
smoke O
stressed O
diameter O
highly O
CTD I-GENE
modulated O
Health O
atrium O
total O
2alpha I-GENE
Stat I-GENE
isoform I-GENE
negative O
substitutions O
biliary O
separated O
tolerated O
infusion O
primase I-GENE
blocking O
1991 O
1990 O
1993 O
1992 O
1995 O
1994 O
1997 O
1996 O
1998 O
work O
intronic I-GENE
mammalian I-GENE
oxide I-GENE
ORF I-GENE
phosphorylates O
acetylcholine I-GENE
indicated O
Abl I-GENE
indicates O
urea O
endometrial O
recovery O
carriers O
provide O
rhesus I-GENE
fever O
transforming I-GENE
CD44 I-GENE
earlier O
CD40 I-GENE
lac I-GENE
fat O
Wild I-GENE
bHLH I-GENE
encompassing O
green I-GENE
order O
mmHg O
internalization O
epinephrine O
Transfection O
production O
shear O
versus O
then O
them O
affected O
remission O
fragment I-GENE
safe O
Analysis O
band O
penetration O
they O
postulated O
Control O
oxygen O
echocardiography O
classified O
l O
deficient O
reasonable O
seedlings O
Csk I-GENE
Type O
VE O
network O
CsA O
vessels O
verapamil O
medicine O
snRNPs I-GENE
standard O
forskolin O
carried O
detecting O
pressor O
agarose O
created O
National O
+/ I-GENE
+- I-GENE
+, I-GENE
incorporated O
CREB I-GENE
preoperative O
dodecyl O
Cell O
another O
implicated O
AIDS O
deaminase I-GENE
approximately O
rates O
observations O
ELISA O
B I-GENE
intestine O
enhancing O
corresponded O
ubiquitous O
Gene I-GENE
target O
gp120 I-GENE
binds O
Neurospora I-GENE
solely O
minus O
E12 I-GENE
manner O
Instead O
contents O
latency O
strength O
pleural I-GENE
latter O
subjects O
mutants I-GENE
completed O
backcross O
viscosity O
extending O
involving O
phase O
assessed O
autopsy O
manifested O
Mean O
QT O
adenine O
calculated O
E1A I-GENE
E1B I-GENE
responded O
reserve O
Xenopus I-GENE
UmuD I-GENE
ovarian O
PAI I-GENE
PAL I-GENE
blotting O
palindrome O
latent I-GENE
hrs O
electrophoresis O
screening O
adequate O
do O
dl O
de O
preferred O
degradation O
dt O
dL O
covering O
colloid O
dT O
observed O
depends O
cytoplasmic I-GENE
projections O
cattle O
techniques O
unable O
cooperation O
glutamine I-GENE
we O
terms O
assays O
wk O
wt I-GENE
linkage O
received O
essentially O
SAPK I-GENE
Cdk2 I-GENE
transmission O
Conversely O
supplementation O
ETS I-GENE
tone O
Initial O
codon O
mutations O
seizure O
aminotransferase I-GENE
Transient O
families O
concerning O
autocrine O
applied O
cytotoxic O
inhibit O
reciprocal O
air O
aim O
aid O
characterizing O
LD50 O
(+) I-GENE
comparative O
confirmed O
perform O
recurrent O
atopic O
ribonuclease I-GENE
plates O
lithium O
independent O
Institute O
pylori I-GENE
counterparts O
hand O
Y I-GENE
catheter O
kept O
femoral O
1972 O
ARDS O
contact O
the O
cytosine O
cisplatin O
Kaposi O
thyroid I-GENE
cervix O
similarities O
passive O
Gal I-GENE
transformed O
S2 I-GENE
Gag I-GENE
plasma I-GENE
CD23 I-GENE
progressed O
boxes O
lymphoma O
temporally O
DNase I-GENE
immunosuppressive O
night O
starvation O
fluoride O
occlusion O
lineages O
born O
Stable O
neomycin I-GENE
/ I-GENE
Leu I-GENE
cortical O
participation O
elucidate O
conformation O
Gram O
substitution O
cardiomyopathy O
post O
herpes I-GENE
tetramer I-GENE
months O
situated O
digestion O
bound O
dehydrogenase I-GENE
compression O
nodal O
people O
mutated O
conservation O
way O
ESTs I-GENE
was O
lowest O
encodes O
desipramine O
encoded I-GENE
true O
absent O
responding O
reproductive O
ancestral O
maximum O
crystal O
cancers O
unusually O
polyps O
histologically O
aorta O
muscular O
evidence O
conserved O
BACKGROUND O
physical O
circulatory O
test O
concurrent O
scores O
omega I-GENE
hippocampal O
interval O
modules I-GENE
Pharmacia O
together O
angiogenesis O
concept O
bolus O
global O
adhesions O
zone O
monocytes O
cochlear O
brown O
protective O
transposon I-GENE
hepatocytes O
responders O
perceived O
respiratory O
prophylactic O
presented O
altering O
p O
RAST O
mucosal I-GENE
liposomes O
gut O
dependently O
upper O
CML O
PCR O
repetitive O
PCI I-GENE
CMV O
appear O
shares O
uniform O
sequential O
During O
supporting O
burn O
genes I-GENE
mRNA I-GENE
appears O
change O
precursor I-GENE
SG I-GENE
trial O
domains I-GENE
SD O
pancreatitis O
regardless O
extra I-GENE
marked O
phosphodiesterase I-GENE
translational O
marker O
rarely O
inositol I-GENE
hematocrit O
prove O
senile O
BSP I-GENE
frameshift O
live O
ischemia O
ischemic O
menstrual O
F I-GENE
envelope I-GENE
symptomatic O
fixed O
radiotherapy O
uncharacterized O
Magnetic O
cap I-GENE
cat O
labeled O
SBF I-GENE
can O
trans O
MMC O
heart O
AVP I-GENE
p107 I-GENE
cimetidine O
serum I-GENE
cDNA I-GENE
ERK I-GENE
posttranscriptional O
," O
dialysis O
discussion O
means O
nystagmus O
flank O
criterion O
Heparin O
product I-GENE
southern O
residues O
produce O
compatibility O
goal O
provirus O
accelerated O
typical O
tagged O
albicans I-GENE
nerve I-GENE
Chi O
displayed O
leptin I-GENE
outer I-GENE
brain O
Genetic O
Jak I-GENE
statistical O
coli I-GENE
cold O
Ro I-GENE
proteases I-GENE
RT I-GENE
RV O
=. O
RP I-GENE
RR O
RS I-GENE
vicinity O
RD I-GENE
RA O
RB I-GENE
RH O
RI I-GENE
non O
R1 I-GENE
R2 I-GENE
adrenaline O
tails O
half O
not O
determinants I-GENE
now O
discuss O
nor O
lineage O
susceptibility I-GENE
inversion O
drop O
entirely O
domain I-GENE
nematode O
significantly O
sugars O
Hepatitis I-GENE
year O
et O
shown O
space O
increase O
receiving O
viable O
shows O
Renal O
divergence O
diagnostic O
advantages O
oligonucleotide I-GENE
care O
fungus I-GENE
rearrangements O
LVEF O
deprivation O
transition O
MMTV I-GENE
paxillin I-GENE
support O
lambda I-GENE
blind O
striking O
Sprague O
variables O
There O
comprised O
directly O
comprises O
message I-GENE
size O
sheep O
Chlamydia O
Localization O
Response O
nutrition O
mostly O
that O
asymmetric O
transverse O
than O
recruit O
CA3 O
magnesium O
anatomic O
intrauterine O
remained O
correction O
Combined O
abnormalities O
Schizosaccharomyces I-GENE
Phe I-GENE
January O
objective O
impairment O
begin O
Unlike O
successive O
] O
renal O
failure O
implications O
Fifty O
duplication O
typically O
cholerae I-GENE
hairpin O
femur O
Role O
testis I-GENE
HSF I-GENE
HSE O
stained O
proportion O
only O
HSV I-GENE
stain O
Crohn O
replicative O
telomeric O
peritoneal O
cannot O
differentiating O
glutathione I-GENE
decarboxylase I-GENE
Dopamine I-GENE
pituitary I-GENE
kilodalton I-GENE
irradiation O
EMG O
burst O
physically O
anchored I-GENE
namely O
actively O
angina O
hypercapnia O
LDL I-GENE
3 I-GENE
Members O
between O
import O
postoperatively O
analyzed O
article O
aromatase I-GENE
dynein I-GENE
Primary O
Cd O
segmental O
COS O
characterization O
PET O
evaluable O
ILK I-GENE
amine I-GENE
learning O
postnatal O
amino O
markedly O
kinases I-GENE
Twenty O
avian I-GENE
external O
suspected O
CO2 O
glomerulonephritis O
developing O
these O
syndromes O
IL6 I-GENE
orientation O
topoisomerase I-GENE
mucus O
sterol I-GENE
attributed O
MKP I-GENE
ubiquitin I-GENE
develop O
proto I-GENE
media O
investigated O
NS1 I-GENE
NS3 I-GENE
SDS O
severe O
restorations O
coordinate O
laboratories O
charged O
edema O
valuable O
EPO I-GENE
inflammatory O
Examination O
ribosomal I-GENE
Molecular O
death O
angiotensin I-GENE
dopaminergic O
improvement O
treatment O
invasive O
real O
psi I-GENE
early I-GENE
using O
recipient O
WAF1 I-GENE
benefit O
t I-GENE
output O
dilution O
exposed O
nucleic O
transfections O
duration O
hemorrhage O
viral I-GENE
SaO2 O
ssDNA I-GENE
recorded O
hepatitis I-GENE
conservative O
deficit O
content O
assembly O
snRNA I-GENE
ovulation O
equivalent O
sedimentation O
snRNP I-GENE
transported O
vasodilator O
complementation O
src I-GENE
central O
enzymatic O
greatly O
antibody I-GENE
aortic O
protease I-GENE
inclusion O
cyclophosphamide O
homodimer I-GENE
involvement O
operator I-GENE
intervention O
log O
area O
assumed O
start O
cats O
low O
allergic O
Ad5 I-GENE
J O
delayed O
posterior O
lymph O
irreversible O
embedded O
restores O
Gel O
TnI I-GENE
600 O
fusions I-GENE
transporters I-GENE
pole O
describe O
reliability O
hospitals O
inactivation O
storage O
poor O
germline I-GENE
noncoding O
computerized O
peak O
elastase I-GENE
Notch I-GENE
pool O
insertions O
controlled O
mitochondria O
HMPAO O
titration O
signalling O
month O
-[ I-GENE
pretreatment O
health O
nodes O
amplitudes O
very O
apoptosis O
Transcriptional O
-- O
-, I-GENE
-. O
-) I-GENE
-( O
sedation O
gallbladder O
still O
Ymax O
TSH I-GENE
GUS I-GENE
enhancement O
canonical O
abundant O
K562 O
thickness O
fractional O
modify O
selective O
trunk O
strong O
tRNA I-GENE
urokinase I-GENE
vasodilation O
amount O
granulocyte I-GENE
family I-GENE
requiring O
S1 I-GENE
vasopressin I-GENE
S6 I-GENE
RET I-GENE
S4 I-GENE
analyzing O
aimed O
REM O
conventional O
contains O
monocytic O
taken O
injury O
terminally I-GENE
lowering O
conformational O
lipoprotein I-GENE
producing O
SS I-GENE
SR I-GENE
SP I-GENE
SV O
SU I-GENE
ST O
SH I-GENE
nine O
SC O
SA O
spontaneous O
SF I-GENE
SE O
history O
f1 I-GENE
CAS I-GENE
CAP I-GENE
isoenzymes I-GENE
CAT I-GENE
CAK I-GENE
cows O
lacks O
species O
CAD I-GENE
expiratory O
baculovirus O
permissive O
MBq O
mesenchymal O
prognostic O
derived O
promoter I-GENE
invasion O
horizontal O
nephropathy O
a O
morphine O
preferential O
enzymes O
microinjection O
spectra O
diets O
deterioration O
egg I-GENE
chicks O
help O
urine O
mucosa O
held O
thermal O
MIP I-GENE
kinetic O
GAP I-GENE
cardiovascular O
lateral O
selenium O
absence O
systems O
differed O
CBF1 I-GENE
CBF2 I-GENE
food O
foot O
yr O
SFV I-GENE
fully O
ACTH I-GENE
stopped O
referred O
heavy I-GENE
undetectable O
positioned O
circadian O
Env I-GENE
beyond O
event O
unspliced O
since O
viability O
safety O
inactivated O
7 O
myocardium O
None O
According O
base O
ion O
undergo O
Copyright O
encoding O
reflected O
incubated O
propranolol O
horse I-GENE
fibrillation O
identity O
Delta I-GENE
hundred O
shifted O
bowel O
basal O
signaling O
authors O
translation I-GENE
OUTCOME O
cysteine I-GENE
toward O
newborns O
MMPI O
randomly O
juice O
substantial O
WBC O
pharmacokinetics O
concentration O
null I-GENE
organs O
monophosphate O
potentiates O
labour O
With O
towards O
350 O
Thr I-GENE
rho I-GENE
position O
alpha I-GENE
The O
serotonin I-GENE
prostatic I-GENE
Total O
prolongation O
mobile O
clear O
phytohemagglutinin I-GENE
nonspecific O
velocity O
fetal O
putida I-GENE
phenomenon O
parameters O
Similarly O
Lck I-GENE
N2O O
biopsy O
While O
combinations O
during O
exhibiting O
transgenic O
transferrin I-GENE
alteration O
underlying O
withdrawal O
x O
ZAP I-GENE
scanning O
napus I-GENE
undergoes O
schizophrenic O
culture O
schizophrenia O
close O
Neither O
polymorphic O
probable O
platelet I-GENE
probably O
conditions O
HBsAg I-GENE
statistically O
missing O
zipper I-GENE
both O
sputum I-GENE
sensitive O
histamine O
experimental O
battery O
Mr O
proton I-GENE
guanine I-GENE
vessel O
implanted O
described O
transactivated O
Most O
describes O
EcoRI I-GENE
maintenance O
collected O
carboxyl O
partly O
0001 O
N I-GENE
determination O
liver O
Current O
while O
transcripts I-GENE
covalently O
loop I-GENE
vectors O
Furthermore O
EIA I-GENE
terminator O
simian I-GENE
baseline O
glycogen I-GENE
monomeric I-GENE
belong O
FAK I-GENE
ester O
composition O
sham O
used O
temporary O
fatty I-GENE
optic O
001 O
000 O
uses O
005 O
older O
myeloma O
systolic O
distances O
HEF1 I-GENE
reviewed O
effector O
useful O
Prevention O
remaining O
lacking O
evaluate O
showing O
FLI1 I-GENE
finding O
success O
Previously O
proline O
signal I-GENE
manifest O
immunization O
translated O
MAIN O
CFTR I-GENE
Dawley O
histopathological O
AMI O
delivered O
reconstituted O
AMP I-GENE
minimal I-GENE
thyroxine O
run O
processing O
stem O
step O
nerves O
kDa I-GENE
neonates O
TFIID I-GENE
Committee O
replacement O
block O
Elk I-GENE
71 O
neoplasms O
nonsense O
Their O
.( O
.) O
., O
." I-GENE
segregation O
tryptophan I-GENE
injection O
hybridized O
TRUNCATED O
heterogeneous I-GENE
electrophoretic O
similar O
Interleukin I-GENE
autologous O
estrogen I-GENE
To O
Tl O
tomography O
Tc O
kidney O
amounts O
oncoprotein I-GENE
TR I-GENE
A1 I-GENE
application O
A3 I-GENE
TM I-GENE
electrical O
TK I-GENE
TH I-GENE
TF I-GENE
TG I-GENE
TB I-GENE
TA O
AA O
AC I-GENE
AD O
AF I-GENE
T7 I-GENE
T4 I-GENE
AM I-GENE
T3 O
granuloma O
glomerular O
assayed O
AS I-GENE
AR I-GENE
AT I-GENE
AV O
structure O
independently O
correlated O
e O
Ag I-GENE
required O
Al O
An O
depth O
correlates O
At O
requires O
amphotericin O
hypothyroidism O
ammonia I-GENE
Non O
Sp1 I-GENE
Sp3 I-GENE
excluded O
wave O
trough O
cellular O
gender O
cyclosporine O
oxidoreductase I-GENE
clotting I-GENE
glycoproteins I-GENE
plays O
macrophages O
cell O
evoked O
experiment O
volatile O
; O
commercial O
Comparative O
focused O
SWI4 I-GENE
northern O
Children O
preferentially O
products I-GENE
constitutive O
gene I-GENE
examining O
untranslated O
stabilization O
addressed O
frame O
remains O
WORDS O
vehicle O
started O
becomes O
OBJECTIVE O
homeobox I-GENE
averaged O
VIII I-GENE
inhibitor I-GENE
control O
links O
sought O
dominant I-GENE
TOF O
junctions O
defective O
genomes O
arrangement O
vesicular O
HIF I-GENE
peroxisome I-GENE
circular O
aureus I-GENE
SRC I-GENE
Specific O
seropositive O
NH2 I-GENE
crassa I-GENE
dilatation O
bipartite O
facilitated O
sperm O
anticoagulant I-GENE
including O
mentioned O
converting I-GENE
EGF I-GENE
chemical O
Multiple O
exclusion O
temporal O
RAR I-GENE
FGF I-GENE
frontal O
functional O
gels O
p16 I-GENE
front O
immunoglobulin I-GENE
hemagglutinin I-GENE
magnitude O
mode O
raised O
cytogenetic O
inputs O
inverted O
constitute O
measure O
IFN I-GENE
corticosteroids O
special O
PKR I-GENE
CEA I-GENE
occupied O
PKB I-GENE
PKC I-GENE
PKA I-GENE
PKN I-GENE
completely O
1980 O
determining O
route O
diminished O
times O
counterpart O
prospective O
randomized O
Deletion O
precisely O
quality O
subacute O
management O
data O
achieved O
relations O
ASA I-GENE
final O
prone O
cyt I-GENE
R I-GENE
manifestation O
TFI I-GENE
morbidity O
epidermal I-GENE
submitted O
Anti I-GENE
providing O
calcitonin I-GENE
distinguished O
exhibit O
unchanged O
msec O
Other O
mycobacteria O
need O
EBNA2 I-GENE
emptying O
able O
pivotal O
detector O
aldosterone O
connected O
preparations O
intrinsic O
evolutionarily O
consequences O
spleen O
Growth I-GENE
synovial O
partners O
based O
( O
rash O
reactive I-GENE
bases O
inherited O
Elimination O
sulfur O
Moloney O
clathrin I-GENE
overall O
120 O
121 I-GENE
122 O
123 O
124 I-GENE
125 I-GENE
126 O
128 I-GENE
procedures O
Italian O
gray O
processes O
1beta I-GENE
processed O
contain O
Protein I-GENE
embryonic O
computed O
Rac1 I-GENE
humans O
canine O
computer O
operated O
phospholipase I-GENE
state O
correctly O
Pseudomonas I-GENE
neither O
kidneys O
Src I-GENE
comparable O
importance O
efficiency O
key O
distribution O
limits O
strains O
manifestations O
estimation O
neoplastic O
Platelet I-GENE
Low O
luteal O
crystalline O
addition O
discrimination O
cent O
slowly O
treat O
esterase I-GENE
diversity O
retrospective O
releasing I-GENE
arginine I-GENE
expenditure O
smoking O
falciparum O
novel O
synergistically O
neuron I-GENE
surface O
examined O
sarcoma I-GENE
lambs O
autoantibodies O
recipients O
anaerobic O
parts O
promoters I-GENE
effect O
renin I-GENE
frequently O
polymorphism O
supernatant O
neuropathy I-GENE
i O
MAPK I-GENE
well O
Experiments O
trials O
BF I-GENE
GST I-GENE
BB I-GENE
coexpression O
accurate O
BI I-GENE
dose O
sources O
NADH I-GENE
distant O
TIF I-GENE
coordination O
density I-GENE
microtubule I-GENE
Br O
Despite O
By O
definitive O
fate O
disappearance O
260 O
burden O
264 O
sequencing O
immediately O
prominent O
loss O
necessary O
lost O
sizes O
alternatively O
sized O
B6 I-GENE
B7 I-GENE
B1 I-GENE
B2 I-GENE
glycoprotein I-GENE
cognate I-GENE
U5 I-GENE
U4 I-GENE
U6 I-GENE
phenomena O
library O
U2 I-GENE
home O
EEG O
P450 I-GENE
competitor O
broad O
However O
overlap O
inflammation O
ROS I-GENE
Seventy O
? O
limitations O
ps I-GENE
expansion O
p38 I-GENE
variation O
neutrophil I-GENE
embryos O
anchorage O
UV O
US O
compatible O
myeloid O
recognizes O
equally O
previously O
ultrasound O
receptor I-GENE
additional O
synthesized O
PMA O
CGP I-GENE
PMN I-GENE
recruited O
furosemide O
vasculitis O
hr O
hazardous O
neutral O
gain O
highest O
cells O
phagocytic O
PLZF I-GENE
converted O
limit O
spectrometry O
display O
tissues O
generating O
exogenous O
MSH I-GENE
education O
cerebrospinal O
chromosome O
functions O
parathyroid I-GENE
Like O
pathways O
additionally O
phosphorus O
bcl I-GENE
gt11 O
shunt O
Academic O
persistent O
juxtamembrane I-GENE
portion O
diagnosis O
indirectly O
similarity O
dissolution O
dynamic O
obstruction O
coactivator I-GENE
whose O
segments O
presents O
rescue O
downstream O
hypertensive O
activation O
govern O
affect O
precursors I-GENE
immunized O
solution O
vector O
cholesterol I-GENE
enhance O
washout O
lysosomal I-GENE
hemodynamics O
likely O
evaluated O
even O
neo I-GENE
nef I-GENE
IgG I-GENE
IgE I-GENE
IgA I-GENE
new O
construction I-GENE
neu I-GENE
particulate O
coefficient O
men O
neurotoxicity O
met I-GENE
Patients O
mer I-GENE
active O
100 O
101 I-GENE
104 O
105 I-GENE
recessive O
Mutations O
transfected O
permit O
suitable O
mobility I-GENE
Also O
soybean I-GENE
counts O
tertiary O
mortality O
type I-GENE
calf I-GENE
lungs O
CONCLUSIONS O
composite O
disruption O
transiently O
adult O
V I-GENE
room O
thymic I-GENE
Cbl I-GENE
suggestive O
root O
give O
Whereas O
involve O
degenerate O
risk O
aging O
predictors O
elicited O
Rho I-GENE
MyoD I-GENE
nodules O
undergoing O
replacing O
All O
attempt O
third O
mutagenesis O
ablation O
Ala I-GENE
maintain O
substrates O
every O
Alu I-GENE
fetus O
responsive I-GENE
budding I-GENE
gastrointestinal O
before O
kappaB I-GENE
personal O
PRL I-GENE
, O
PRK O
better O
differently O
weeks O
GH I-GENE
overcome O
maximal O
donors O
deletion O
combination O
fixation O
atherosclerosis O
modification O
therapy O
bronchial O
retrotransposon I-GENE
meat O
Indeed O
arrested O
ventilation O
acoustic O
meal I-GENE
bone O
bond O
inserts O
apolipoprotein I-GENE
cardiopulmonary O
RNAs I-GENE
conductance I-GENE
literature O
Factor I-GENE
extract O
NLS O
gradient O
restricted O
crucial O
HMR I-GENE
RNAP I-GENE
particles O
adhesion I-GENE
HMG I-GENE
extensively O
linear O
halothane O
ascending O
296 O
240 O
chromosomal I-GENE
cosmid O
SSB I-GENE
features O
grade O
uric O
cytoskeletal O
ECG O
neuromuscular O
girls O
Press O
exposures O
DNAs O
p54 I-GENE
p55 I-GENE
p50 I-GENE
p53 I-GENE
begins O
distance O
anxiety O
database O
preparation O
matter O
biochemical O
enables O
membranes O
Intron I-GENE
modern O
seed I-GENE
seen O
seem O
POZ I-GENE
POU I-GENE
chest O
heptad I-GENE
PO2 O
norepinephrine O
regular O
testicular I-GENE
Biological O
subtotal O
observation O
medical O
m I-GENE
dog O
points O
fungal I-GENE
probe O
implying O
attempts O
explain O
folded O
sugar I-GENE
judged O
reconstruction O
stop O
Organization O
fields O
vincristine O
microscopy O
inactive O
architecture O
fertility O
ears O
reference O
testing O
alterations O
hydrocarbon I-GENE
subject O
02 O
03 O
00 O
01 O
06 O
07 O
04 O
05 O
09 O
connective O
omeprazole O
tolerance O
C I-GENE
triplet O
lymphocyte I-GENE
vitamin O
androgen O
loading O
suggested O
agonist O
resistant O
Abnormal O
against O
cartilage O
contribution O
Syrian I-GENE
Amino O
presumably O
appeared O
height O
ether O
Electrophoretic O
targeting O
eradication O
basis O
three O
Early O
phosphopeptide I-GENE
interest O
basic I-GENE
C3 I-GENE
C2 I-GENE
C1 I-GENE
C6 I-GENE
C4 I-GENE
CK I-GENE
obtained O
CI O
CO I-GENE
CM I-GENE
CL O
CC O
suppress O
CA I-GENE
CG I-GENE
CD O
Epstein I-GENE
CS I-GENE
165 O
CP I-GENE
160 I-GENE
placental I-GENE
CT I-GENE
exception O
Co O
Cl O
acetylation O
Ca I-GENE
hnRNP I-GENE
near O
Cr I-GENE
Cp I-GENE
anchor I-GENE
Cu I-GENE
seven O
concomitant O
diaphragm O
reproducibility O
is O
streptococcal I-GENE
it O
iv O
ii O
anastomosis O
in O
homozygous O
captopril O
mouse I-GENE
if O
grown O
abscess O
: O
make O
V2 I-GENE
potentially O
colonies O
VA O
selectin I-GENE
VF O
VH I-GENE
VI I-GENE
kit I-GENE
pharmacological O
VT O
potentials O
weakly O
programs O
stimuli O
Cdk I-GENE
radioimmunoassay O
squamous O
materials O
801 O
800 O
left O
protocol O
just O
assigned O
identify O
salivary I-GENE
human I-GENE
yet O
calmodulin I-GENE
catalytic O
candidate O
regarded O
character O
affinity O
allele I-GENE
hypersensitive I-GENE
orphan I-GENE
background O
nude O
Arg O
stimulatory I-GENE
rRNA I-GENE
subtilis I-GENE
elderly O
CTL O
chromosomes O
PTH I-GENE
investigations O
PTB I-GENE
PTP I-GENE
initiated O
predicting O
metastatic O
selectable O
heparin O
Evidence O
influenzae O
vaginal O
transactivation O
down O
lies O
cascades I-GENE
Hybridization O
prolactin I-GENE
initial O
erythrocyte I-GENE
TEF I-GENE
influencing O
fraction O
fork I-GENE
DNA I-GENE
form O
some O
m2 O
posttranslational O
Biochemical O
Z I-GENE
220 O
prevents O
attached O
stages O
fractions O
Nuclear I-GENE
gland O
cytoskeleton I-GENE
graft O
generally O
digital O
p70 I-GENE
diet O
fell O
glucocorticoids O
died O
enhancers I-GENE
Drosophila I-GENE
D2 I-GENE
daily O
Second O
amniotic I-GENE
teeth O
pellets O
restored O
GTPases I-GENE
primed O
mild O
skin O
morphology O
primer O
milk O
retention O
operons I-GENE
suicide O
depend O
disorders O
technique O
parenchyma O
0 O
analogous O
CCAAT I-GENE
yeast I-GENE
gestation O
LHR I-GENE
suppressors O
did O
permits O
round O
phosphorylated O
Test O
intronless O
bacterial I-GENE
targets O
acidosis O
deficiencies O
template O
P19 O
RelA I-GENE
isoforms I-GENE
filled O
COOH O
Changes O
box I-GENE
shift O
somatic O
simultaneous O
diagnosed O
cyst O
biopsies O
spatially O
EBPbeta I-GENE
When O
regeneration O
UL80 I-GENE
transplant O
sympathetic O
additive O
encode O
tachycardia O
ecdysone O
aspirin I-GENE
AUC O
AUG O
acceptable O
---- I-GENE
antigens I-GENE
tandem O
effort O
ligase I-GENE
growing O
making O
repressing O
dosage O
predict O
agent O
sample O
spanning O
Induction O
rays O
tilt O
strikingly O
hypersensitivity O
14C O
pure O
pathway O
map O
142 O
143 I-GENE
140 I-GENE
pectoris O
may O
max O
fed O
accessory I-GENE
designed O
grow O
man O
tetrofosmin O
neck O
elongation I-GENE
q I-GENE
cascade O
switch O
esters O
Removal O
stability O
differs O
adhesive O
group O
monitor O
GlcNAc I-GENE
main O
uptake O
WT1 I-GENE
within O
env I-GENE
killer O
synergistic O
Shc I-GENE
killed O
possess O
proteins I-GENE
glutamyl I-GENE
Measurement O
cAMP I-GENE
abnormal O
medial O
alpha2 I-GENE
living O
alpha1 I-GENE
interference O
dioxide O
correct O
after O
G I-GENE
mechanisms O
Tumor I-GENE
vinyl O
language O
frequent O
first O
nutritional O
1B I-GENE
long O
specificity O
carry O
mammary O
little O
glycosylase I-GENE
participates O
1a I-GENE
1b I-GENE
Post O
eyes O
inefficient O
continuous O
adrenergic I-GENE
accurately O
ambulatory O
coefficients O
Replacement I-GENE
11 O
10 O
13 O
12 O
15 O
14 O
17 O
16 O
19 O
18 O
protected O
PCO2 O
were O
nifedipine O
DM O
DC O
DA I-GENE
Regulation O
DT I-GENE
DR I-GENE
modality O
DP I-GENE
20S I-GENE
date O
efficient O
isolate O
Da I-GENE
potential O
TGF I-GENE
performance O
switching O
channel O
201 O
200 O
pain O
COPD O
normal O
incidence O
catalase I-GENE
telomere I-GENE
autophosphorylation O
beta I-GENE
tract O
pair O
especially O
sigma I-GENE
D3 I-GENE
D1 I-GENE
precise O
rating O
WD I-GENE
show O
WR O
dinucleotide O
threshold O
We O
metabolites O
MK O
black O
helix I-GENE
RII I-GENE
extracellular I-GENE
histone I-GENE
designated O
Large I-GENE
nearly O
distinctly O
conjunction O
gel O
consist O
median O
yield O
summary O
subtype I-GENE
relative O
unaltered O
boundaries O
behind O
Selective O
reading O
across O
deletions O
myotubes O
parental O
Each O
cervical O
according O
Laboratory O
among O
stretches O
cancer O
maintained O
exhibits O
spans O
adults O
Surf I-GENE
tumour I-GENE
capable O
shortening O
transformants O
offered O
dramatic O
those O
sound O
kappa I-GENE
profiles O
Detection O
bromide O
margin O
endothelial I-GENE
catenin I-GENE
Factors O
characteristics O
secondary O
cluster I-GENE
protein I-GENE
movements O
different O
same O
speech O
myoD I-GENE
Bcl I-GENE
autonomously I-GENE
oil O
adipocytes O
acetyl I-GENE
intermittent O
hydroxy I-GENE
consisted O
proximal I-GENE
adrenal O
ethyl O
asthma O
A2 I-GENE
4 I-GENE
Although O
extensive O
HPLC O
genome O
mos I-GENE
inhibition O
mol O
identifying O
serves O
chamber O
either O
neuronal O
drainage O
Moreover O
epitope O
specifies O
undifferentiated O
VDR I-GENE
thromboxane I-GENE
Nef I-GENE
specified O
images O
New O
microgram O
Reverse I-GENE
gross O
confirm O
fluids O
Met I-GENE
EFIA I-GENE
expressing O
moderate O
intravenous O
measuring O
Interaction O
T2 I-GENE
each O
unusual O
Genomic O
T1 O
AP I-GENE
island O
insect O
SHBG I-GENE
mixed O
trypsin I-GENE
erythropoietin I-GENE
implantation O
tyrosine I-GENE
granules O
enough O
Ac I-GENE
Ab I-GENE
woman O
arranged O
Significantly O
Wee1 I-GENE
USF I-GENE
haloperidol O
contralateral O
acetate O
general O
immunoprecipitation O
examine O
melatonin O
again O
assessing O
hybrid O
As O
field O
antimicrobial O
students O
durations O
important O
excretion O
inhibited O
vagotomy O
resembles O
nutrient O
ovary O
resolution O
represent O
SIV O
Val I-GENE
allergy O
nucleolar I-GENE
zinc I-GENE
porcine I-GENE
children O
duplicated O
responsiveness O
TAR I-GENE
Yeast I-GENE
diffuse O
TAF I-GENE
heterogeneity O
fall O
difference O
capillary O
neurological O
mothers O
skeletal I-GENE
progesterone I-GENE
adrenoceptor I-GENE
biological O
periodontal O
CTCF I-GENE
glioma O
Only O
phage I-GENE
further O
residue O
barrier O
lactamase I-GENE
abl I-GENE
caffeine O
endothelin I-GENE
NF1 I-GENE
movement O
HCV I-GENE
malaria O
ranged O
K I-GENE
component O
HCB O
favourable O
operating O
subclinical O
search O
published O
formation O
toxicity O
pathological O
cystic I-GENE
transit O
establish O
readily O
NSAID O
distinct O
Studies O
two O
comparing O
LTR I-GENE
echocardiographic O
constructs I-GENE
American O
controlling O
immunoreactive I-GENE
varying O
none O
hour O
strain O
strategies O
specialized O
+) O
compare O
oocytes O
share O
myoblasts O
minimum O
chimera I-GENE
numbers O
molecularly O
cooperativity O
needs O
vacuolar I-GENE
thallium O
acts O
CHOP I-GENE
maps O
causing O
PP2A I-GENE
Tyr I-GENE
YHPD O
blood O
response O
randomised O
coat I-GENE
dispensable O
chimeric I-GENE
Ty1 I-GENE
infant O
through O
existence O
visceral O
24 O
25 O
26 O
27 O
20 O
21 O
22 O
sodium O
28 O
29 O
late O
detected O
microscopic O
antithrombin I-GENE
superoxide I-GENE
good O
2R I-GENE
males O
2A I-GENE
2B I-GENE
compound O
association O
subcutaneously O
easily O
subunit I-GENE
pregnant O
micro O
2b I-GENE
positions O
repeating O
harboring O
mRNAs I-GENE
mental O
exons O
fish O
idea O
mm2 O
extended O
lysis O
thick O
acting O
E7 I-GENE
E6 I-GENE
E1 I-GENE
GATA I-GENE
E3 I-GENE
E2 I-GENE
EM O
births O
EF I-GENE
EC I-GENE
eosinophil O
members O
ET I-GENE
beginning O
ES O
ER I-GENE
benefits O
conducted O
top O
reinforced O
copper I-GENE
instances O
utilized O
inhibits O
oncoproteins I-GENE
homologues O
hamsters O
least O
182 O
regulation O
186 I-GENE
X2 O
compartment O
CArG I-GENE
muscles O
18F O
sensitization O
part O
differentiate O
percentage O
b I-GENE
cyclic I-GENE
cyclin I-GENE
largely O
dogs O
recording O
hCG I-GENE
Smad I-GENE
toe O
treated O
ages O
antihypertensive O
aged O
depending O
onset O
extracted O
capillaries O
kD I-GENE
eggs O
most O
p34cdc2 I-GENE
significant O
extremely O
kb O
kg O
Consistent O
dystrophy I-GENE
Cdc42 I-GENE
organism O
heterodimerization O
joining O
particularly O
disturbances O
swelling O
perfused O
relation O
malignant O
fine O
find O
urchin I-GENE
210 O
nervous O
distributed O
8 O
131I O
cysts O
Thirty O
express O
breast O
Ser O
spikes O
Mycobacterium O
common O
Female O
gated O
tended O
individual O
genomic O
Plasma I-GENE
CD3 I-GENE
TCR I-GENE
smallest O
vascular I-GENE
TCF I-GENE
hippocampus O
responses O
complementary O
complement I-GENE
DDP O
analogues O
City O
holoenzyme I-GENE
HIS3 I-GENE
inspiratory O
metazoan I-GENE
folding O
reverse I-GENE
radicals O
annual O
foreign O
raf I-GENE
supply O
simple O
Zta I-GENE
newborn O
dietary O
Mutation O
theophylline O
zeta I-GENE
throughout O
fused O
create O
intracellular O
vertebrate I-GENE
splenic O
screened O
microspheres O
gas O
understand O
gag I-GENE
porphyrin O
ubiquitination O
bile O
solid O
replaced O
itself O
(> O
fluorouracil O
ADR1 I-GENE
regulate O
anaesthesia O
benign O
subcutaneous O
relatively O
fibrosis I-GENE
development O
attenuation O
assignment O
Promoter O
purpose O
infused O
homologies O
task O
joint O
P388 O
entry O
chemistry O
prevention O
subretinal O
nucleoprotein I-GENE
JNK1 I-GENE
shape O
alternative O
injuries O
alignment O
superficial O
cut I-GENE
transcriptase I-GENE
fentanyl O
source O
p21ras I-GENE
hybridization O
precipitation O
anomalies O
cognitive O
follows O
indication O
ErbB I-GENE
rheumatoid I-GENE
often O
metabolic O
abundantly O
back O
strongest O
examples O
pronounced O
scale O
glycosylation O
contacts O
C57BL O
affects O
integration O
per O
endotoxin I-GENE
patient O
300 O
immunoprecipitated O
spectrin I-GENE
candidiasis O
O I-GENE
restrictive O
glycol O
gynecologic O
Barr I-GENE
reticulum O
HTLV I-GENE
E1a I-GENE
Experiment O
genital O
frames O
pathologic O
subcellular O
virions O
infected O
corticosterone O
boys O
unstimulated O
directed O
supplementary O
rejection O
casein I-GENE
pRb I-GENE
groove I-GENE
precipitated O
constant O
metal O
Cross O
single O
cure O
serological O
titer O
triglycerides I-GENE
hemodynamic O
% O
Max I-GENE
Maf I-GENE
endocrine O
aggregates O
prepared O
lens O
fructose I-GENE
silencing O
2000 O
presenting O
initiating O
pneumoniae I-GENE
Golgi I-GENE
amplified O
intensive O
effectors I-GENE
critical O
fatal O
assay O
deiodinase I-GENE
severely O
shock I-GENE
supine O
dimer O
bleeding O
antigen I-GENE
carotid O
recombinants I-GENE
3H O
insertion O
3C I-GENE
depression O
giving O
access O
LexA I-GENE
European O
exercise O
body O
dissection O
exchange I-GENE
440 O
objects O
healing O
others O
oxidative O
tremor O
extreme O
39 O
38 O
respiration O
Chinese O
33 O
32 O
31 O
30 O
37 O
36 O
35 O
34 O
composed O
fourfold O
named O
FU O
acidification O
FB O
decrease O
Treatment O
limb O
FK O
FL I-GENE
FN I-GENE
dermatitis O
Ft O
Fc I-GENE
themselves O
MDV I-GENE
Aspergillus I-GENE
insufficiency O
transient O
normalized O
iii O
amygdala O
F1 I-GENE
account O
f I-GENE
F9 O
effectively O
native O
lysine O
varied O
Activation O
regions O
attachment O
Cardiac I-GENE
kindling O
profile O
ABA I-GENE
flanking O
ABL I-GENE
leukemia I-GENE
collection O
HGF I-GENE
yielded O
prostate O
primers O
HIV I-GENE
overexpression O
bind O
lines O
correspond O
synthase I-GENE
subsequently O
gestational O
catabolism O
located O
chemotherapeutic O
FK506 O
histological O
< O
junction O
greater O
LPS I-GENE
day O
synaptic O
identified O
/- O
virulent O
identifies O
melanomas O
Previous O
activate O
From O
proliferating I-GENE
programmed O
lesion O
sexual O
rev I-GENE
repress O
messenger I-GENE
barley I-GENE
rel I-GENE
asthmatic O
red I-GENE
Stage O
CSF I-GENE
clarify O
approaches O
likelihood O
interaction O
deprived O
homodimers I-GENE
chicken I-GENE
facilitate O
arterial O
Administration O
Significance O
reached O
YACs O
monkey I-GENE
intermediate O
Association O
scans O
explanation O
environmental O
phorbol O
ubiquitously O
abolishes O
inversely O
amplitude O
abolished O
threefold O
antitrypsin I-GENE
Pax I-GENE
cytoplasm O
curves O
unlikely O
have O
homeodomain I-GENE
follicle I-GENE
dementia O
apparently O
preterm O
min O
mid O
serine I-GENE
unless O
prednisone O
32P O
eight O
preliminary O
transcript I-GENE
dorsal O
stranded I-GENE
Some O
disease O
methyltransferase I-GENE
artificially O
normally O
selection O
supported O
elimination O
pulsed O
HeLa O
RhoA I-GENE
N2 O
antiserum O
knowledge O
controls O
York O
inferior O
equilibrium O
peptide I-GENE
lobe O
biosynthetic O
beam O
bean I-GENE
timing O
areas O
substrate I-GENE
organ O
hGH I-GENE
cycles O
enhancer I-GENE
enhances O
pombe I-GENE
exists O
national O
ocular O
intensity O
Various O
enhanced O
homeotic I-GENE
kbp O
phases O
pattern O
routine O
progress O
boundary O
alveolar O
Study O
biosynthesis O
S I-GENE
Recently O
users O
retinol I-GENE
taking O
prokaryotic I-GENE
equal O
morphologic O
transplantation O
placebo O
masses O
otherwise O
detailed O
relevant O
removal O
estimating O
copies O
indicators O
define O
Comparison O
phylogenetic O
hemostasis O
transfusion O
bulk O
deep O
bulb O
multi I-GENE
hypotension O
microsatellite I-GENE
appearance O
value O
promotes O
agar O
promoted O
extracts O
pheromone O
biphasic O
operon I-GENE
almost O
Mechanism O
partner I-GENE
regression O
SOD I-GENE
) O
administration O
indistinguishable O
coronary O
thyrotropin I-GENE
MBP I-GENE
practice O
intravascular O
blockers O
Doppler O
center I-GENE
neural O
CYC1 I-GENE
thought O
sets O
comparisons O
muscle O
arising O
CONCLUSION O
Willebrand I-GENE
glycine O
stored O
voltage O
MEF2 I-GENE
localize O
absorption O
Haemophilus O
ectopic O
conjugated O
285 O
match O
resolved O
tests O
dimers I-GENE
endoderm O
28S I-GENE
insert O
like I-GENE
excluding O
qualitative O
chick I-GENE
soft O
Scale O
classical O
Forty O
proper O
Gal4 I-GENE
estradiol O
chains I-GENE
noise O
lipid O
slight O
histologic O
host O
immature O
simplex I-GENE
although O
EWS I-GENE
panel O
about O
actual O
Stroop O
Japan O
introduced O
predictor O
Two O
chronic O
termini O
female O
proteolysis O
1986 O
1987 O
1985 O
1982 O
1983 O
adolescent O
elastin I-GENE
immunotherapy O
1988 O
1989 O
spread O
receptors I-GENE
Experimental O
but O
repeated O
partially O
microvascular O
variations O
minutes O
plutonium O
rabbits O
OBJECTIVES O
deaths O
pig O
periods O
IF O
83 O
rhythm O
identities O
glutamate I-GENE
48 O
49 O
46 O
47 O
44 I-GENE
45 O
42 O
detail O
40 I-GENE
41 O
ingestion O
Altogether O
Phase O
out O
transfection O
bundle O
enlargement O
oral O
Thus O
UL26 I-GENE
augmented O
limited O
oxygenation O
cytosol O
implants O
sleep O
enteric O
assembled O
cytokines O
poorly O
feeding O
G2 I-GENE
G1 I-GENE
intron O
Additionally O
under O
divergent O
GT I-GENE
GS I-GENE
GR I-GENE
rise O
vitreous O
GC I-GENE
GA I-GENE
upstream O
GM I-GENE
monkeys O
anemia I-GENE
believed O
Gs I-GENE
induction O
Gy O
Ga O
osmotic O
cooperative O
consistent O
guidelines O
estimates O
direct O
surrounding O
estimated O
blue O
mutational O
organisms O
selected O
supplied O
jaundice O
TTF I-GENE
injections O
asymmetry O
ethanol O
represented O
acceptor O
Zn I-GENE
thromboplastin I-GENE
leaves O
changed O
Surprisingly O
CpG O
changes O
hydrophobic O
Group O
sulfate I-GENE
would O
hospital O
E2F I-GENE
m3 O
menopausal I-GENE
Recombinant I-GENE
assessment O
pleckstrin I-GENE
mM O
mL O
excellent O
must O
abundance O
mg O
mm O
ml O
mo O
dimeric I-GENE
mu I-GENE
tissue I-GENE
sucrose O
ms O
postexposure O
telomerase I-GENE
unilateral O
hemoglobin I-GENE
enterotoxin I-GENE
IME1 I-GENE
end O
globular O
lesions O
IIA I-GENE
toxin I-GENE
adjacent O
toxic O
ancestor O
III I-GENE
description O
HCMV I-GENE
arthritis O
polymerase I-GENE
plakoglobin I-GENE
threonine I-GENE
parallel O
Japanese O
complexity O
correlation O
interpretation O
embryogenesis O
over O
promoterless O
staining O
replicating I-GENE
Here O
QRS O
condition O
400 O
blots O
diseases O
chromatography O
prevented O
CHO O
diseased O
echo O
indeed O
aeruginosa I-GENE
Four O
filling O
fitness O
DBP I-GENE
lasting O
nitrite I-GENE
peaks O
emphysema O
adenylate I-GENE
newly O
nitrogen O
p130 I-GENE
associate O
free O
cirrhosis O
homologous O
W I-GENE
mononuclear O
AFP I-GENE
TIMP I-GENE
equine I-GENE
days O
filter O
IkappaBalpha I-GENE
smokers O
BTB I-GENE
onto O
already O
coding O
primary O
hearing O
adopted O
dysfunction O
their O
activators I-GENE
confirming O
Determination O
motility O
analgesic O
analgesia O
glucose O
Fur I-GENE
centered O
tool O
serve O
injected O
pyramidal O
roles O
zero O
classes O
plasmid O
diuretic O
seminal I-GENE
fashion O
rat I-GENE
ras I-GENE
unaffected O
ray O
relapse O
- I-GENE
isolated O
predominantly O
Disruption O
retinoblastoma I-GENE
isolates O
effectiveness O
dermal O
complexed O
though O
glands O
complexes I-GENE
GTPase I-GENE
carcinoma O
coil O
papillomavirus I-GENE
potency O
flow O
Its O
OxyR I-GENE
reductions O
random O
CD34 I-GENE
solutions O
ipsilateral O
analogue O
availability O
situations O
Substitution O
mixture O
subcloned O
fluid O
heterozygosity O
tuberculosis O
despite O
report O
twice O
interspersed O
automatic O
electrodes O
L12 I-GENE
detection O
cofactor I-GENE
purpura O
Staphylococcus I-GENE
capacity O
feline I-GENE
finger I-GENE
approach O
discovery O
visualization O
oxidation O
weak O
however O
larynx O
contamination O
oxidase I-GENE
lipase I-GENE
improve O
adapting O
Among O
protect O
amoxicillin O
ventricular O
p300 I-GENE
Vibrio I-GENE
epidemic O
viruses O
GAL4 I-GENE
Southern O
been O
belongs O
expected O
cdc2 I-GENE
lactis O
drugs O
bladder O
anteroposterior O
Crk I-GENE
phosphatidylinositol I-GENE
microns O
n O
lesser O
procedure O
tumorigenesis O
pathology O
interacts O
)]. O
containing O
suggest O
wound O
complex I-GENE
phenotype O
several O
satellite I-GENE
phosphatases I-GENE
". O
HPV I-GENE
action O
portal I-GENE
immunohistochemical O
cycle O
narrow O
possessed O
fusion I-GENE
greatest O
hearts O
possesses O
proposed O
starting O
5S I-GENE
rodent O
dopamine I-GENE
cotranscribed O
transmembrane I-GENE
modulate O
functionally O
monitored O
vibration O
HCO3 O
IOP O
gave O
tracheal O
D I-GENE
bands O
addicts O
KRAB I-GENE
RXR I-GENE
advanced O
apart O
59 O
58 O
Lys O
55 O
54 I-GENE
57 O
56 O
51 O
50 O
53 O
52 O
specific I-GENE
Lyn I-GENE
HR O
HS I-GENE
successfully O
HT O
selectivity O
Arabidopsis I-GENE
HL I-GENE
HB I-GENE
indirect O
HA I-GENE
HF I-GENE
HD I-GENE
Hz O
Hb I-GENE
Salmonella I-GENE
Ha I-GENE
Hg O
He O
cord O
core I-GENE
deleted O
hepatic I-GENE
disappeared O
eye O
permitted O
limitation O
H2 I-GENE
H3 I-GENE
H1 I-GENE
H4 I-GENE
plus O
monocytogenes O
ppb O
adrenoceptors I-GENE
leukemias O
presence O
obtaining O
ppm O
carbachol O
existed O
vaccination O
transform O
metabolism O
synthesis O
head I-GENE
medium O
ADR O
ADP I-GENE
PIP2 O
epsilon I-GENE
differences O
heat I-GENE
sustained O
removed O
ADH I-GENE
portions O
vivo O
phosphate I-GENE
adenosine I-GENE
nM O
creatinine O
constructed O
epidemiological O
nm O
no O
whereas O
tip O
ng O
setting O
implant O
nt O
node O
picture O
TRAF2 I-GENE
EST I-GENE
Double O
preceding O
discharge O
longer O
corresponding O
fasted O
serious O
nuclei O
remarkable O
particular O
focus O
leads O
functioned O
remarkably O
passage O
environment O
charge I-GENE
promoting I-GENE
determinations O
Day O
methyl O
broadly O
frequencies O
emphasizes O
level O
accumulation O
Krox I-GENE
Rex I-GENE
slower O
PPARgamma I-GENE
trend O
Rep I-GENE
pore I-GENE
Rel I-GENE
bacteria O
substitute O
spectral O
axial O
phosphatase I-GENE
retroviral I-GENE
alkaline I-GENE
multidrug I-GENE
confer O
water O
groups O
[ O
unidentified O
healthy O
Dictyostelium O
pediatric O
resonance O
mimicked O
inducing O
dioxin I-GENE
glucuronidase I-GENE
Therefore O
islet O
properties O
cmH2O O
memory O
These O
immunoglobulins I-GENE
employed O
cases O
Expression O
reflux O
modified O
attacks O
elastic O
achieve O
iodine O
nursing O
DHFR I-GENE
phosphorylate O
stroke O
performed O
hydrogen O
lipoproteins I-GENE
requirements O
1 I-GENE
vital O
fourth O
coiled O
clone O
ligated O
liquid O
Sf9 O
purification O
branched I-GENE
joins O
Zip I-GENE
blocker O
mainly O
blocked O
supplemented O
apex O
modalities O
MICs O
offers O
Effects O
Using O
TPA O
TPN O
fetoprotein I-GENE
evolution O
warranted O
TPR O
feature O
term O
tobacco I-GENE
dsRNA I-GENE
possibilities O
Stat5a I-GENE
individually O
weighted O
autoregulation O
biologically O
infarct O
factors I-GENE
UGA O
plasmids O
MADS I-GENE
hemorrhagic O
gram O
experienced O
theory O
pathogenic O
mapping O
SV40 I-GENE
methylation O
motion O
turn I-GENE
place O
swine O
SMRT I-GENE
childhood O
1000 O
origin O
dimethyl O
glucagon I-GENE
plastin I-GENE
necessarily O
fibrinogen I-GENE
stimulation O
clinical O
Such O
white O
anesthetized O
gives O
PDZ I-GENE
season O
released O
heterologous O
copy O
population O
wide O
endoplasmic O
require O
oligonucleotides O
r O
sera O
poisoning O
outcome O
transport O
pre I-GENE
pro I-GENE
BPV I-GENE
steers O
any O
conversion O
transcription I-GENE
Mapping O
fracture O
resembling O
strengths O
multiple O
botulinum I-GENE
erbB I-GENE
erbA I-GENE
probes O
latex O
tendon O
galactosidase I-GENE
considered O
later O
secreting O
peptides I-GENE
cortex O
slope O
Mutational O
Research O
spacer O
phosphotransferase I-GENE
polyadenylated O
cyclosporin O
homology I-GENE
homologs I-GENE
Fyn I-GENE
Leishmania I-GENE
H I-GENE
dye O
primates O
Similar O
closure O
reveal O
eosinophils O
aluminum O
endorphin I-GENE
predicted O
mapped O
reveals O
malformations O
wortmannin O
fails O
detect O
inhibitory I-GENE
ways O
subsequent O
review O
circulating O
inhibitors O
outside O
Cip1 I-GENE
ECHO O
arteries O
reaction O
region O
23 O
Chronic O
PGE2 O
color O
colony I-GENE
period O
poly O
sampling O
60 O
61 O
62 O
medication O
64 O
65 O
66 O
67 O
68 O
69 O
Bacillus I-GENE
immunodeficiency I-GENE
oxygenase I-GENE
500 O
direction O
pseudogene I-GENE
isomerase I-GENE
Together O
ophthalmic O
CAAT I-GENE
case O
chromatographic O
synthetase I-GENE
premature O
refractory O
Cloning O
irrespective O
formalin O
coupled I-GENE
capping I-GENE
author O
shifts O
Grb2 I-GENE
events O
week O
Ets I-GENE
lymphomas O
synthetases I-GENE
IR I-GENE
IU O
IV I-GENE
driven O
persons O
vestibular O
IM O
IL I-GENE
footprint O
changing O
IE I-GENE
NFAT I-GENE
fasting O
antibodies I-GENE
inhalation O
cytosolic I-GENE
Is O
It O
without O
components O
In O
termination O
model O
bodies O
If O
United O
transactivate O
when O
actions O
spliced O
differentiation O
blot O
rose O
seems O
except O
thrombotic O
histidine O
samples O
immunosorbent O
disrupt O
Many O
neuroblasts O
confined O
accepted O
acute O
particle I-GENE
aqueous O
reduces O
neurologic O
Pit I-GENE
reduced O
Since O
competition O
HT3 I-GENE
HT2 I-GENE
subtypes O
intact O
provided O
depletion O
provides O
FGFR I-GENE
TRH I-GENE
TRE I-GENE
on O
of O
); O
discussed O
hypothalamus O
concentrations O
or O
hypothermia O
reactions O
instruments O
spinal O
Identification O
determine O
abrogate O
toxicological O
strictly O
there O
cultured O
dispersion O
detectable O
Letter O
nitric I-GENE
cultures O
energy O
750 O
regard O
jun I-GENE
Cotransfection O
Quantitative O
promote O
faster O
terminus O
applying O
99mTc O
lysozyme I-GENE
Serum I-GENE
strongly O
HindIII I-GENE
taste O
measurement O
metastasis O
cbl I-GENE
lumbar O
diverged O
glycosylated O
intra O
bilirubin O
5 I-GENE
atropine O
immunity O
deviation O
CNS O
separate O
ICE I-GENE
includes O
nucleus O
included O
cytotoxicity O
clinically O
bilateral O
PFK I-GENE
curve O
citrate I-GENE
all O
lack O
surgical O
systemic O
follow O
vWF I-GENE
synthetic O
subjected O
prostaglandin I-GENE
program O
lacZ I-GENE
presentation O
activities O
belonging O
liter O
far O
induce O
heme O
IIIB I-GENE
inducibility O
stimulus O
evaluation O
Binding O
prolonged O
Class I-GENE
employing O
rats O
ten O
rate O
design O
functioning O
what O
sub O
sum O
ticks O
brief O
overload O
version O
PLC I-GENE
segmentation I-GENE
Short O
tags O
behaviour O
relaxation O
allows O
stiffness O
repressor I-GENE
conditioning O
lysates O
vertebral O
inorganic O
Evaluation O
aberrant O
Overall O
Liver O
cadherin I-GENE
grafts O
minor O
horses O
flap O
definition O
immersion O
MGA O
antibiotics O
known O
presumed I-GENE
primate O
equation O
1alpha I-GENE
v I-GENE
division O
osteosarcoma O
EGFR I-GENE
arise O
transduction O
influenced O
advantage O
rather O
influences O
activator I-GENE
Structural O
cytokine O
Gln O
Akt I-GENE
reflect O
Gly O
cadmium O
Glu O
constitutively O
short O
melanogaster I-GENE
turnover O
developed O
Oct I-GENE
adverse O
susceptible O
might O
alter O
return O
L I-GENE
accumulate O
Raf I-GENE
Rac I-GENE
Ran I-GENE
Rat I-GENE
Ras I-GENE
done O
characterized O
nicotine O
weight O
generation O
+)- I-GENE
+), O
loops O
More O
hyperbilirubinemia O
alcohol O
discrete O
induces O
Eight O
induced O
remodeling O
fiber O
solvent O
generate O
dexamethasone O
galactose I-GENE
antigenic I-GENE
Partial O
circuit O
consequence O
feed O
radical O
linking O
defects O
abrogated O
" O
temperature O
utilization O
leading O
interact O
180 O
ventricle O
recovered O
headache O
Antibodies O
phosphoenolpyruvate I-GENE
pump I-GENE
Rev I-GENE
retinal O
imprinted O
GTP I-GENE
GCN2 I-GENE
optical O
GCN4 I-GENE
double O
cost O
HVS O
exert O
globulin I-GENE
mesoderm O
depleted O
leukocyte I-GENE
pathogens O
genetically O
donor O
stenosis O
added O
measures O
reach O
77 O
76 I-GENE
75 O
74 O
73 O
72 O
Diagnosis O
70 I-GENE
measured O
79 O
78 O
mineral O
PaCO2 O
indomethacin O
.). O
contig O
heterodimer O
hip O
his O
proteasome I-GENE
Value O
Both O
shared O
PHA I-GENE
investigate O
activity O
BP I-GENE
intergenic O
alanine I-GENE
collateral O
defense O
injecting O
are O
(+)- I-GENE
arm O
declined O
thrombocytopenia O
distinctive O
libraries O
various O
consecutive O
numerous O
recently O
creatine I-GENE
initially O
ulceration O
attention O
MHC I-GENE
Janus I-GENE
disturbance O
African O
competent O
AND O
c I-GENE
arrhythmias O
Collectively O
became O
ANP I-GENE
context O
], O
]. O
]) I-GENE
reside O
regulates O
distress O
sepsis O
regulated O
fibres O
pH O
goats O
decline O
complication O
due O
strategy O
whom O
reduction O
LMP1 I-GENE
pg O
eIF I-GENE
pi I-GENE
BALB O
usage O
demand O
plants O
RESULTS O
laparoscopic O
behavior O
murine I-GENE
neurons O
twofold O
stimulates O
lengths O
stimulated O
widely O
9 O
prerequisite O
higher O
Ile O
Cox O
usually O
immunofluorescence O
lower O
abnormality O
chickens O
analysis O
CoA I-GENE
machinery O
SPECT O
pollen O
abilities O
Measurements O
competitive O
intervals O
questions O
Taken O
RPA I-GENE
phospholipid I-GENE
tablet O
majority O
workers O
exclusively O
associations O
apnea O
aggregation O
subfamily I-GENE
toluene O
modifications O
shaped O
systematically O
polymers O
separately O
unstable O
rearrangement O
essential O
ulcers O
understood O
gradually O
ions O
lyase I-GENE
Upstream O
fragments I-GENE
mitotic O
M I-GENE
Epo I-GENE
Insulin I-GENE
intense O
vaccine O
housekeeping O
glaucoma O
range O
Saccharomyces I-GENE
gamma I-GENE
cutoff O
Approximately O
cdk2 I-GENE
mitosis O
diameters O
sequence I-GENE
question O
fast O
hexamer O
hepatocyte I-GENE
analyze O
sections O
Animals O
U1 I-GENE
potassium O
footprinting O
U3 I-GENE
delta I-GENE
ventilated O
nmol O
characteristic O
fluctuations O
z O
called O
VEGF I-GENE
associated I-GENE
myogenin I-GENE
associates O
ribonucleoprotein I-GENE
myogenic I-GENE
leucine I-GENE
generates O
problems O
generated O
TNF I-GENE
allowing O
Homozygous O
amphetamine O
VZV I-GENE
contributes O
fluorescence O
Sequence O
uPA I-GENE
weights O
ternary O
demonstrates O
once O
Based O
resistance O
tumours O
adjustment O
issues O
supershift O
UAS O
stably O
mEq O
stable O
include O
dramatically O
transversion O
mutation I-GENE
EHV I-GENE
surfactant I-GENE
breathing O
iliac O
engineered I-GENE
P I-GENE
electron O
artery O
drinking O
LAD O
Competition O
demonstrated O
noted O
concluded O
smaller O
FEV1 O
Biol O
fold O
State O
acid I-GENE
somatostatin I-GENE
pretreated O
multivariate O
Stat5 I-GENE
Stat3 I-GENE
degree O
myosin I-GENE
IGF I-GENE
explore O
separation O
CBF I-GENE
larger O
opiate I-GENE
suggests O
CBP I-GENE
stimulating I-GENE
examinations O
ORF1 O
ORF3 O
ORF2 O
duct O
apo I-GENE
motor O
use O
from O
consumption O
& O
germ I-GENE
few O
examination O
psoriasis O
ORFs O
vesicle O
infection O
cooperate O
virulence I-GENE
rabbit I-GENE
women O
ALL O
stabilized O
Characterization O
stabilizes O
UT O
metastases O
T3R I-GENE
SREBP I-GENE
tat I-GENE
tau I-GENE
tap I-GENE
Northern O
tag O
recognized O
tal I-GENE
serial O
syndrome O
six O
occur O
prognosis O
instead O
p190 I-GENE
tuberculous O
tension O
maternal I-GENE
wrist O
Hence O
light I-GENE
interrupted O
subdomains O
locomotor O
%, O
PaO2 O
%. O
%) O
closely O
Ca2 I-GENE
interpreted O
133 I-GENE
132 O
131 O
130 I-GENE
136 O
135 O
139 O
contaminated O
superior O
longitudinal O
transferase I-GENE
permanent O
clusters O
Cas I-GENE
material O
impaired O
Pra I-GENE
profound O
Pro I-GENE
transmitted O
CaM I-GENE
mitral O
naloxone O
myelin I-GENE
related I-GENE
88 O
89 I-GENE
sectional O
82 O
our O
80 O
81 O
86 I-GENE
87 O
84 O
85 O
category O
semen O
bactericidal O
cerebral O
supports O
integrated O
excess O
angiography O
This O
maintains O
affective O
RNase I-GENE
pancreatic O
organic O
g O
hence O
ionic O
MuLV O
embryo O
KSHV I-GENE
hitherto O
K1 I-GENE
corticosteroid I-GENE
U14 I-GENE
Increased O
unknown O
immunoassay O
chemotherapy O
inner O
mandibular O
reversed O
reflecting O
congenital O
isolation O
infectious O
limiting O
KS O
patients O
KP O
laevis I-GENE
linker I-GENE
stomatitis I-GENE
linked O
diazepam I-GENE
angle O
rearranged I-GENE
After O
olfactory O
which O
= O
%), O
%). O
criteria O
who O
lidocaine O
eukaryotes O
nucleotide I-GENE
class I-GENE
atypical O
High O
Pol I-GENE
HepG2 O
currently O
Coronary O
Chemical O
planning O
microM O
99m O
spindle O
leg O
vancomycin O
ear O
micron O
microm O
local O
microg O
proviral I-GENE
GPI I-GENE
ones O
NIH O
Re O
differential O
Chr O
cleavage O
view O
predictive O
requirement O
Rb I-GENE
FDG O
acquired O
distantly O
p27 I-GENE
p21 I-GENE
bacteriophage I-GENE
antiarrhythmic O
mCi O
reperfusion O
breakpoints O
exerts O
identification O
closed O
crude O
variability O
ability O
Differential O
neonatal O
hypothesis O
LCR I-GENE
RNA I-GENE
Parkinson O
duplex O
RNP I-GENE
sequenced O
unclear O
wall O
antioxidant O
NaCl O
midazolam O
CD4 I-GENE
Finally O
sequences I-GENE
respect O
pulmonary O
CD8 I-GENE
electrocardiogram O
forms O
STAT5 I-GENE
STAT3 I-GENE
STAT1 I-GENE
VP16 I-GENE
IE1 I-GENE
IE2 I-GENE
Jun I-GENE
alters O
outflow O
monoclonal I-GENE
determinant O
nickel O
sufficient O
confers O
improved O
present O
unlike O
PLP I-GENE
ejection O
herpesvirus I-GENE
CDK I-GENE
will O
CDP I-GENE
wild I-GENE
pleiotropic O
layer O
mutant I-GENE
motif I-GENE
thus O
chloramphenicol I-GENE
filamentous I-GENE
epitopes I-GENE
dual O
myb I-GENE
perhaps O
proteinase I-GENE
ribosome I-GENE
radiation O
cross O
member O
propensity O
anhydrase I-GENE
largest O
units O
difficult O
ARS I-GENE
ARC I-GENE
ARF I-GENE
undertaken O
load O
excessive O
obtain O
fibrin I-GENE
divergently O
contractile O
duodenal O
rapid O
Fas I-GENE
point O
Diagnostic O
lymphocytes O
identical O
saturation O
putative O
Drug O
T I-GENE
facial O
variants I-GENE
dimensional O
helpful O
Within O
Influence O
represses O
agents O
repressed O
), O
because O
luminal O
115 I-GENE
114 I-GENE
117 O
growth I-GENE
111 O
110 I-GENE
113 I-GENE
112 O
119 O
118 O
leaf O
lead O
lean O
markers O
detergent O
Alzheimer I-GENE
missense O
leader O
trout I-GENE
reductase I-GENE
analysed O
fluorescent O
analyses O
mite I-GENE
rare O
testosterone O
extension O
column O
dependence O
carries O
carrier I-GENE
own O
en I-GENE
amylase I-GENE
maize I-GENE
tumorigenic O
transfer I-GENE
* I-GENE
Upon O
rDNA I-GENE
var I-GENE
vas O
macrophage I-GENE
isoproterenol O
triggered O
corneal O
volume O
automated O
Following O
auxiliary I-GENE
made O
Ten O
whether O
TATA I-GENE
record O
below O
infants O
demonstrate O
--> I-GENE
resting O
carbohydrate O
myc I-GENE
permeability I-GENE
percent O
smears O
other O
Five O
branch O
conclusion O
palindromic O
homolog I-GENE
radiolabeled O
coupling O
necrosis I-GENE
junB I-GENE
Site I-GENE
transfectants O
volumes O
